PT999849E - Utilizacao de lbp no tratamento da septicemia - Google Patents

Utilizacao de lbp no tratamento da septicemia

Info

Publication number
PT999849E
PT999849E PT98928139T PT98928139T PT999849E PT 999849 E PT999849 E PT 999849E PT 98928139 T PT98928139 T PT 98928139T PT 98928139 T PT98928139 T PT 98928139T PT 999849 E PT999849 E PT 999849E
Authority
PT
Portugal
Prior art keywords
lbp
septicemia
treatment
utilization
therapeutic agent
Prior art date
Application number
PT98928139T
Other languages
English (en)
Portuguese (pt)
Inventor
Ralf Reiner Schumann
Norbert Lamping
Original Assignee
Max Delbrueck Centrum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Delbrueck Centrum filed Critical Max Delbrueck Centrum
Publication of PT999849E publication Critical patent/PT999849E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751Bactericidal/permeability-increasing protein [BPI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT98928139T 1997-07-11 1998-04-04 Utilizacao de lbp no tratamento da septicemia PT999849E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19729810A DE19729810C2 (de) 1997-07-11 1997-07-11 Mittel zur Sepsistherapie, seine Herstellung und seine Verwendung

Publications (1)

Publication Number Publication Date
PT999849E true PT999849E (pt) 2003-01-31

Family

ID=7835437

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98928139T PT999849E (pt) 1997-07-11 1998-04-04 Utilizacao de lbp no tratamento da septicemia

Country Status (9)

Country Link
US (1) US6949512B1 (https=)
EP (1) EP0999849B1 (https=)
JP (1) JP2001509488A (https=)
AT (1) ATE223227T1 (https=)
DE (2) DE19729810C2 (https=)
DK (1) DK0999849T3 (https=)
ES (1) ES2183376T3 (https=)
PT (1) PT999849E (https=)
WO (1) WO1999002178A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2108372A1 (en) * 2008-04-09 2009-10-14 Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften Novel antimicrobial peptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0760849A1 (en) * 1993-04-30 1997-03-12 Incyte Pharmaceuticals, Inc. Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
WO1995005393A2 (en) * 1993-08-18 1995-02-23 Morphosys Gesellschaft Für Proteinoptimierung Mbh Lipopolysaccharide-binding and neutralizing peptides
WO1995008560A1 (en) * 1993-09-24 1995-03-30 Centocor, Inc. Novel peptides useful for inhibiting binding of lipopolysaccharides (lps) by lipopolysaccharide binding protein (lbp)
US5837810A (en) * 1994-03-15 1998-11-17 The Scripps Research Institute Polypeptides of lipopolysaccharide binding protein
US5990082A (en) * 1997-10-22 1999-11-23 Xoma Corporation Uses of lipopolysaccharide binding protein

Also Published As

Publication number Publication date
DK0999849T3 (da) 2003-01-06
ATE223227T1 (de) 2002-09-15
WO1999002178A1 (de) 1999-01-21
US6949512B1 (en) 2005-09-27
DE19729810A1 (de) 1999-01-14
JP2001509488A (ja) 2001-07-24
DE19729810C2 (de) 2000-01-13
DE59805440D1 (de) 2002-10-10
EP0999849A1 (de) 2000-05-17
ES2183376T3 (es) 2003-03-16
EP0999849B1 (de) 2002-09-04

Similar Documents

Publication Publication Date Title
EA199800946A1 (ru) Концентрированный препарат антител
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
ATE339507T1 (de) Erythropoietin-analog-menschliches serum-albumin fusionsprotein
DK0914144T3 (da) Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi
FI954978L (fi) Modifioidut proteiini- ja peptidilääkeaineet
NO980915L (no) Rekombinante anti-CD4-antistoff egnet for human terapi
DE69825625D1 (de) Aminobiguanide und ihre verwendung zur desinfektion von kontaktlinsen und konservierung von pharmazeutischen zubereitungen
BR9509172A (pt) Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica
DE69719754D1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
EE9700288A (et) Asatsükloalkaani derivaadid, nende valmistamine ja kasutamine ravis
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
DE69714451D1 (de) Prionbindende proteine und deren verwendungen
ITMI942663A0 (it) Proteine ricche in idrossiprolina e formulazioni farmaceutiche e cosmetiche che le compongono
FR2718451B1 (fr) Dérivés de peptides boroniques, leur préparation et leur application en thérapeutique.
NZ500216A (en) Beta-amyloid peptide-binding proteins and pharmaceutical use
DE69831084D1 (de) Beta-defensine
PT999849E (pt) Utilizacao de lbp no tratamento da septicemia
FI956353L (fi) Farmaseuttiset valmisteet ja niiden käyttö etenkin neurodegeneratiivisten sairauksien hoidossa
PT983300E (pt) Sais peptidicos de bpc com actividade organo-protectora, processo para a sua preparacao e sua utilizacao em terapia
NO980375D0 (no) Humant MP52 Arg protein
FI972965L (fi) Uusia peptidejä, niiden valmistus ja käyttö
TR199700842T1 (xx) �nsan DNase I Varyantlar�.
EE9800108A (et) Valgu S-100b kasutamine ravimites ja valku S-100b sisaldavad ravimid
BR9808216B1 (pt) composição farmacêutica ou cosmética compreendendo retinóide com melibiose, uso da mesma e método para o tratamento cosmético de alterações associadas com o envelhecimento da pele e/ou o exoesqueleto.
RU96111557A (ru) Способ лечения нейросенсорной тугоухости